Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Centessa Pharmaceuticals plc (Nasdaq: CNTA) has announced its participation in two upcoming investor conferences:

• Guggenheim Genomic Medicines and Rare Disease Days
  Date: April 3, 2023, Location: New York, NY, Fireside Chat: 9:35 AM ET
• Jefferies & Venrock Boston Biotech Summit
  Date: April 12, 2023

Presentation materials along with live webcasts and archived recordings will be accessible through the investor relations section of Centessa's website. Established to innovate in patient care, Centessa focuses on developing medicines across various stages targeting significant health issues.

BOSTON and LONDON, March 27, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that members of its management team will participate in the following investor conferences:

Event: Guggenheim Genomic Medicines and Rare Disease Days
Date: Monday, April 3, 2023
Location: New York, NY
Fireside Chat: 9:35 AM ET

Event: Jefferies & Venrock Boston Biotech Summit
Date: Wednesday, April 12, 2023

Where applicable, the presentation slides and/or a link to the live webcast of the event, as well as an archived recording, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.

About Centessa Pharmaceuticals
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit http://www.centessa.com/, which does not form part of this release.

Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com

FAQ

What events is Centessa Pharmaceuticals attending in April 2023?

Centessa Pharmaceuticals will participate in the Guggenheim Genomic Medicines and Rare Disease Days on April 3, 2023, and the Jefferies & Venrock Boston Biotech Summit on April 12, 2023.

What is the date and time for Centessa Pharmaceuticals' fireside chat?

The fireside chat for Centessa Pharmaceuticals at the Guggenheim Genomic Medicines and Rare Disease Days is scheduled for April 3, 2023, at 9:35 AM ET.

Where can I find the presentation materials for Centessa Pharmaceuticals' investor conferences?

Presentation slides and links to live webcasts for Centessa Pharmaceuticals' conferences will be available on their investor relations website.

What is the focus of Centessa Pharmaceuticals as a clinical-stage company?

Centessa Pharmaceuticals aims to discover and develop transformative medicines for patients across various health indications.

What stock symbol is associated with Centessa Pharmaceuticals?

Centessa Pharmaceuticals trades under the stock symbol CNTA.